Breast cancer screening in Colombia
- Routine care
Breast cancer is the most common cancer in women worldwide. Found small, it is usually curable; finding it small is the whole point of screening.
See it in 3D: Mammary gland lobes · Lactiferous ducts · Nipple
What it is
Screening looks for breast cancer in women without symptoms. In Colombia, Resolución 3280 de 2018 (Ruta de Promoción y Mantenimiento de la Salud) sets a clinical breast examination every year from 40 and a two-view mammogram every two years from 50 to 69. Results are reported in BI-RADS categories: normal or benign results continue the schedule, probably benign findings follow the breast cancer care route, and suspicious ones lead to an active search for the woman and a priority biopsy. Women with hereditary or family risk factors are referred to the breast cancer care route. Self-examination is taught as awareness of warning signs, not as a substitute for screening. A woman with symptoms is not screened: she gets a diagnostic workup at any age. How intensely to screen depends on risk. Risk models estimate it from the history: the Gail model uses age, age at first period and first birth, previous breast biopsies (especially atypical hyperplasia), race or ethnicity and first-degree relatives with breast cancer, and gives a five-year and lifetime risk; the Tyrer–Cuzick model adds a detailed family tree, hormonal factors and breast density, so it suits women with a family history better. High risk means a known BRCA1, BRCA2 or other high-penetrance variant (or an untested first-degree relative of a carrier), chest radiation between about 10 and 30 years of age (for example for Hodgkin lymphoma), or an estimated lifetime risk of about 20% or more. These women start earlier, usually from about 25 to 30, with a yearly breast MRI added to mammography, because MRI is the most sensitive test and is not blinded by dense tissue; it is not used for average-risk women because it brings many false alarms and biopsies.
What it looks for
- From 40: clinical breast examination every year (Res. 3280 de 2018).
- From 50 to 69: two-view mammogram every two years; with a normal or benign result (BI-RADS 1 or 2), continue every two years until 69.
- BI-RADS 3: further diagnostic or follow-up steps as the breast cancer care route defines.
- BI-RADS 4A, 4B, 4C or 5: actively find the woman, give a priority results appointment and order a biopsy.
- The history looks for hereditary, family and personal risk factors; if present, refer to the breast cancer care route.
- Warning signs to teach: a lump in the breast or armpit, skin thickening or retraction, colour change, new nipple retraction, new asymmetry, ulcers, and spontaneous or bloody nipple discharge.
- Risk models (Gail, Tyrer–Cuzick) turn the history into an estimated risk; the Gail model does not suit women with a BRCA variant, previous chest radiation or a strong family history, where Tyrer–Cuzick or a genetic assessment fits better.
- High risk (BRCA1, BRCA2 or another high-penetrance variant, chest radiation before about 30, or lifetime risk about 20% or more): yearly breast MRI plus mammography, starting earlier, planned by specialists.
How it is done
- Ask about risk factors: family history of breast or ovarian cancer, known BRCA variant, chest radiation when young, previous breast disease.
- Explain the purpose, benefits and possible discomfort of each test, and why she must come back for the result.
- From 40, examine both breasts and armpits in a private, calm setting, letting her say if anything hurts.
- From 50 to 69, order a two-view mammogram every two years; the result should be read and reported within 15 calendar days.
- Deliver every result and act by BI-RADS category; for 4 or 5, contact her actively and order a biopsy.
- Record the date, test and result, give her a card with the next appointment, and teach the warning signs.
BI-RADS categories that are easy to confuse
| Category | Meaning | What happens next |
|---|---|---|
| 0 | Incomplete: the image cannot be judged yet | More views or ultrasound before any conclusion |
| 1 and 2 | Normal, or a clearly benign finding | Back to routine screening every two years |
| 3 | Probably benign | Short-interval follow-up or diagnostic steps per the breast cancer route; not a biopsy by default |
| 4A, 4B, 4C | Suspicious, from low to high suspicion | Biopsy, with priority |
| 5 | Highly suggestive of cancer | Biopsy, with priority, and fast referral |
| 6 | Cancer already proven by biopsy | Treatment planning |
Common mistakes
- Screening is for women without symptoms. A woman of any age with a lump, skin change or nipple discharge gets a diagnostic workup now, not at her next screening date.
- Under about 40, or in pregnancy and breastfeeding, ultrasound is the first imaging test for a lump.
- Dense breasts hide cancers on mammography; a normal mammogram does not clear a palpable lump, which needs examination, imaging and, if in doubt, a biopsy.
- Delay → a larger tumour → spread to the axillary nodes → harder treatment and lower survival; in Latin America many cancers are still found at advanced stages.
- Women at high risk (BRCA carriers, chest radiation when young) need earlier and more intensive screening planned by specialists, often with MRI.
Next step / When to refer
- BI-RADS 4 or 5: priority biopsy (usually core needle) and referral to the breast cancer care route.
- Any palpable lump, skin retraction, new nipple inversion or bloody discharge: diagnostic imaging and referral, at any age.
- Hereditary or family risk on history: refer to the breast cancer care route and to genetic counselling.
- After 69: decide with the woman, by her health and preferences, whether to continue.
- High-risk woman (BRCA variant, chest radiation when young, very high estimated risk): refer to a breast specialist or high-risk clinic for earlier screening with yearly MRI and mammography.
Common traps
- Monthly self-examination can replace mammography: Res. 3280 teaches it as awareness of warning signs and states plainly that it does not replace the screening tests.
- A palpable lump with a normal mammogram is reassuring: some cancers do not show on mammography, especially in dense breasts, so the lump needs ultrasound and often a biopsy.
- BI-RADS 3 means probably cancer: it means probably benign and is followed up; categories 4 and 5 are the ones that need a biopsy.
- A 35-year-old with a lump is too young for breast cancer: screening ages are for women without symptoms, and any woman with symptoms gets a diagnostic workup.
- Breast MRI is the best test, so every woman should be screened with it: MRI is the most sensitive test but gives many false positives and biopsies; it is kept for high-risk women (BRCA, chest radiation when young, lifetime risk about 20% or more), added to mammography.
Test yourself
Think of the answer, then tap the question to see it.
A 52-year-old with no symptoms asks what breast screening she needs in Colombia. What does Res. 3280 set?
A clinical breast examination every year and a two-view mammogram every two years, continuing to 69 if results are normal or benign.
A screening mammogram is reported as BI-RADS 4B. What should happen next?
Find the woman actively, give her a priority results appointment and order a biopsy; 4 means suspicious.
A 38-year-old has felt a lump for a month. Her friend says she is too young for screening. What is the right approach?
She is not being screened but investigated: any woman with a breast symptom needs a diagnostic workup now, usually ultrasound first at her age, and biopsy if indicated.
Why does a normal mammogram not exclude cancer in a woman with a palpable lump?
Mammography misses some cancers, especially in dense breasts, so a lump still needs ultrasound and, if in doubt, a biopsy.
A 28-year-old had chest radiotherapy for Hodgkin lymphoma at 16. Why does she not wait for the 50-to-69 mammogram schedule?
Chest radiation when young puts her at high risk, like a BRCA carrier: specialists plan yearly MRI plus mammography, usually from about eight years after the radiation and not before 25.
Elsewhere in DurgiPedia
- Mammography and breast ultrasound: BI-RADS in plain words
- Clinical breast examination
- Breast: ducts, lobules and changes with life stage
- Principles of screening
- Screening in women's health: cervical cancer, breast cancer and the Res. 3280 schedule
Connections
See it in 3D3
The structures of Durgical's 3D anatomy where it is found.
← All of obstetrics and gynaecology
Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.
Sources: Resolución 3280 de 2018: lineamientos técnicos y operativos de la Ruta de Promoción y Mantenimiento de la Salud y de la Ruta Materno Perinatal (Ministerio de Salud y Protección Social de Colombia, 2018); Breast Cancer Screening in the Average-Risk Patient (StatPearls Publishing (NCBI Bookshelf), 2024); Screening Mammography in Breast Cancer Detection (StatPearls Publishing (NCBI Bookshelf), 2023); Breast cancer (fact sheet) (World Health Organization, 2026); Breast MRI in Clinical Practice (StatPearls (NCBI Bookshelf), 2023); BRCA Gene Changes: Cancer Risk and Genetic Testing (National Cancer Institute, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
